Our purpose in this project is to begin to turn that fear of cancer, actually America's greatest fear, into a future, not only free of fear, but full of hope.

This new guidance level will further reduce an already minimal risk from lead exposure in candy.

This cancer genome atlas project is all about the progress that is necessary for us to make cancer a chronic and manageable condition that no longer causes the suffering and death that we see all around us.

Over the past decade, prescribing information has grown more and more complex, more and more dense and more difficult to negotiate.

I applaud Congress for the passage of FALCPA. Chairman Joe Barton and Ranking Member John D. Dingell in the House, Energy and Commerce Committee were instrumental in moving this bipartisan legislation forward. Representative Nita Lowey was the original sponsor of the legislation. FDA also applauds the dedication and leadership of the legislation's sponsors in the Senate, which include Senators Judd Gregg and Edward Kennedy.

It will be an important step in our understanding of the genetic components of cancer and the genetic susceptibilities of people affected by cancer.